Jamie S. Pak

NYU Langone Health — United States

Medicine · Health Sciences

11h-index417citations58works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(24), Urinary and Genital Oncology Studies(20), Urological Disorders and Treatments(10), Prostate Cancer Treatment and Research(9), Prostate Cancer Diagnosis and Treatment(8)

Publications57 total

Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results
European Radiology·2026
Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations
Urologic Oncology Seminars and Original Investigations·2025
MP16-18 COMBINATION REGIMEN OF INTRAVESICAL DOCETAXEL, GEMCITABINE, AND CISPLATIN IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
The Journal of Urology·2024· 1 cited
Interaction of patient age and high‐grade prostate cancer on targeted biopsies of MRI suspicious lesions
British Journal of Urology·2024
Transurethral Vapor Ablation in Prostate Cancer
2024
Invited Commentary: Inguinal Lymph Node Dissection: How Are We Doing?
Journal of the American College of Surgeons·2022
Table of Contents
Urology·2021Open Access
PD38-06 A NOVEL RISK PREDICTION MODEL TO TRIAGE DIFFICULT URETHRAL CATHETERIZATIONS
The Journal of Urology·2021
MP48-07 EFFECT OF DELAY TO NEPHROURETERECTOMY AFTER KIDNEY-SPARING TREATMENTS ON PATHOLOGIC AND SURVIVAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA
The Journal of Urology·2021
PD51-11 SIGNIFICANCE OF VISUALLY COMPLETE TRANSURETHRAL RESECTION OF BLADDER TUMOR PRIOR TO NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
The Journal of Urology·2021
A Novel Risk Prediction Model to Triage Difficult Urethral Catheterizations
Urology·2021
Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer
Urologic Oncology Seminars and Original Investigations·2021· 17 cited
Experimenting with county-level COVID-19 data as a substitute for demographic information
Pharmacoepidemiology and Drug Safety·2021
Diagnostic yield of repeat evaluation for asymptomatic microscopic hematuria after negative initial workup
Urologic Oncology Seminars and Original Investigations·2020· 2 cited
A Urology Department's Experience at the Epicenter of the COVID-19 Pandemic
Urology·2020· 6 citedOpen Access
Oncologic outcomes of complete transurethral resection prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Journal of Clinical Oncology·2020· 2 cited
Bladder Preservation for Patients With Bladder Paragangliomas: Case Series and Review of the Literature
Urology·2020· 7 cited
MP24-01 UTILITY OF REPEAT WORKUP FOR ASYMPTOMATIC MICROSCOPIC HEMATURIA AFTER INITIAL NEGATIVE EVALUATION
The Journal of Urology·2020Open Access
MP63-17 SEPSIS PROTOCOL IMPROVES OUTCOMES IN PATIENTS WITH STONE RELATED OBSTRUCTIVE PYELONEPHRITIS
The Journal of Urology·2020
PD60-04 SURVIVAL ANALYSIS AND PREDICTORS OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE IN CLINICAL COMPLETE-RESPONDERS AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
The Journal of Urology·2020
page 1 of 3Next →

Frequent Co-authors

James M. McKiernan(31), G. Joel DeCastro(22), Christopher B. Anderson(13), Danny Lascano(12), Mitchell C. Benson(10), Julia B. Finkelstein(7), Gina M. Badalato(7), Cory Abate‐Shen(6), Kimberly L. Cooper(6), Christopher Haas(6), Sven Wenske(6), Wilson Sui(5), Helena Vila-Reyes(5), Arindam RoyChoudhury(4), Dara Holder(4), Michael Palese(4), Kevin Lee(4), Mark V. Silva(4), Renu K. Virk(3), Daniel Kabat(3)